New Medicare Pilot Program for GLP-1 Starts July 1

Starting July 1, 2026, Medicare will offer a temporary program called the Medicare GLP-1 Bridge. It is a short-term program that may help eligible Medicare Part D beneficiaries access weight loss drugs. For GLP-1 medicine for weight loss and weight management, certain medicines may be covered by Medicare through December 31, 2027.

Some EmblemHealth plans may also cover GLP-1 medications for members with diabetes and other clinical criteria. Providers should refer to the applicable plan’s prior authorization criteria for coverage requirements and additional details. Visit cms.gov for more information on the Medicare GLP-1 Bridge program.